LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 70.27 | 21.74 | 4859 | 6201 | 0.7835 | 0.9411 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 70.27 | 21.74 | 2632 | 6201 | 0.4244 | 0.8005 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 70.27 | 21.74 | 4986 | 6201 | 0.8039 | 0.9472 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 70.27 | 21.74 | 4456 | 6201 | 0.7185 | 0.9206 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 70.27 | 21.74 | 4790 | 6201 | 0.7723 | 0.9377 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 72.24 | 21.74 | 3451 | 6162 | 0.5601 | 0.8626 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 72.24 | 21.74 | 5028 | 6162 | 0.8160 | 0.9507 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 72.24 | 21.74 | 2673 | 6162 | 0.4338 | 0.8051 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 72.24 | 21.74 | 5233 | 6162 | 0.8492 | 0.9603 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 72.24 | 21.74 | 4574 | 6162 | 0.7423 | 0.9282 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 72.24 | 21.74 | 4990 | 6162 | 0.8098 | 0.9489 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 74.21 | 21.74 | 3173 | 6235 | 0.5089 | 0.8412 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 74.21 | 21.74 | 5241 | 6235 | 0.8405 | 0.9579 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 74.21 | 21.74 | 2680 | 6235 | 0.4298 | 0.8035 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 74.21 | 21.74 | 5440 | 6235 | 0.8724 | 0.9668 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 74.21 | 21.74 | 4006 | 6235 | 0.6424 | 0.8945 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 74.21 | 21.74 | 5140 | 6235 | 0.8243 | 0.9532 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 76.18 | 21.74 | 3629 | 6114 | 0.5935 | 0.8758 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 76.18 | 21.74 | 5505 | 6114 | 0.9003 | 0.9744 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 76.18 | 21.74 | 2792 | 6114 | 0.4566 | 0.8163 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 76.18 | 21.74 | 5687 | 6114 | 0.9301 | 0.9823 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 76.18 | 21.74 | 4379 | 6114 | 0.7162 | 0.9196 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 76.18 | 21.74 | 5390 | 6114 | 0.8815 | 0.9692 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 78.15 | 21.74 | 3631 | 6167 | 0.5887 | 0.8741 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 78.15 | 21.74 | 5724 | 6167 | 0.9281 | 0.9818 | MN20160310_N01 | G09 |